HSBC Holdings plc Reiterates “€65.00” Price Target for Gerresheimer AG (GXI)

HSBC Holdings plc set a €65.00 ($76.47) price objective on Gerresheimer AG (ETR:GXI) in a research note issued to investors on Tuesday morning. The brokerage currently has a neutral rating on the stock.

Several other research firms have also issued reports on GXI. Independent Research GmbH set a €78.00 ($91.76) price target on Gerresheimer AG and gave the company a neutral rating in a research report on Wednesday, July 19th. DZ Bank AG reissued a buy rating on shares of Gerresheimer AG in a research report on Monday, July 17th. Deutsche Bank AG set a €82.00 ($96.47) price target on Gerresheimer AG and gave the company a buy rating in a research report on Friday, July 7th. Berenberg Bank set a €75.00 ($88.24) price target on Gerresheimer AG and gave the company a buy rating in a research report on Wednesday, October 11th. Finally, Kepler Capital Markets set a €70.00 ($82.35) target price on Gerresheimer AG and gave the stock a sell rating in a research report on Thursday, July 13th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of Hold and an average target price of €73.14 ($86.05).

Gerresheimer AG (ETR GXI) opened at 66.505 on Tuesday. The firm has a market capitalization of €2.09 billion and a PE ratio of 18.422. Gerresheimer AG has a one year low of €59.97 and a one year high of €79.47. The stock has a 50 day moving average of €64.78 and a 200-day moving average of €70.18.

ILLEGAL ACTIVITY NOTICE: “HSBC Holdings plc Reiterates “€65.00” Price Target for Gerresheimer AG (GXI)” was published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://transcriptdaily.com/2017/10/20/hsbc-holdings-plc-reiterates-65-00-price-target-for-gerresheimer-ag-gxi.html.

About Gerresheimer AG

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply